Patient education would aid compliance

Article

To help improve compliance, patients should be made aware of what a normal intraocular pressure (IOP) is and be informed of their own at each visit to their ophthalmologist, according to Rohit Arora and colleagues from the North Middlesex Hospital, UK.

To help improve compliance, patients should be made aware of what a normal intraocular pressure (IOP) is and be informed of their own at each visit to their ophthalmologist, according to Rohit Arora and colleagues from the North Middlesex Hospital, UK.

In their study, a structured questionnaire was completed by 100 patients attending a glaucoma clinic with chronic open angle glaucoma and ocular hypertension. Questions related to field defects, IOP, treatment and compliance. Their aim was to test patients' knowledge of the condition and therapy and to relate this to treatment compliance.

The investigators found that 13% of patients were unaware that they had glaucoma, however, 87% were aware that the disease has a very serious effect on vision. Forty-seven percent were able to accurately remember the name of their drops, 30% had an appropriate idea but 23% had no idea.

In terms of compliance, 18% depended on family members for the drops, 53% claimed full compliance, 14% admitted to forgetting their drops once in every 15 days, 14% would forget once a month and 20% would forget once in every six months. The main causes of non-compliance were holidays and general forgetfulness.

A significant number, 87%, had no idea about their own IOP and about the pressure range of a normal eye, whilst 80% did not understand the technique or relevance of the field tests. Sixty-four percent were unaware of alternative treatment options and 73% did not know of the existence of helplines and societies.

The team concluded from the study that patients needed to be further educated about the nature of their disease as this would serve to enhance compliance.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
© 2025 MJH Life Sciences

All rights reserved.